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Abstract—Pulmonary hypertension (PHT) is highly prevalent 
in patients with Aortic Stenosis (AS) and significantly increases 
mortality. Correlation between echocardiogram derived right 
ventricular pressure and measured pulmonary artery systolic 
pressure (PASP) by right heart catheterization (RHC) have been 
reported to be poor. Retrospective data of 56 patients with AS 
who underwent coronary angiography and RHC from June 1999 
to 2008 were reviewed. 20 patients (35.1%) had severe PHT with 
PASP > 55 mmHg on RHC. PASP did correlate with the body 
weight (r = 0.473, p<0.01). There was a significant correlation 
between PASP on RHC and RVSP on echo (r = 0.344 p<0.01) but 
a Bland-Altman plot showed poor association. In patients with 
PVR < 3, there was correlation between the PASP and LVEDP 
on RHC (r = 0.655, p<0.001). 34 patients had an estimated RVSP 
<40 mm Hg on echo and 9 (25.7%) of these patients had severe 
PHT on RHC. Using a RVSP cutoff of 40 mmHg, echo had 46.8% 
sensitivity. There was higher mortality at 3 years in patients with 
severe PHT (44% vs. 10.7%, p <0.01) Conclusions: Severe PHT 
was found in up to 35% of patients with AS and had higher 
mortality. Obese patients with AS had a higher likelihood of 
severe PHT. Echocardiography underestimates PHT in patients 
with AS. PHT is related to diastolic dysfunction in these patients. 
RHC should be considered in select patients with aortic stenosis 
in order to risk stratify and assess for early aortic valve 
replacement, in patients in whom a reliable TR jet velocity is 
unobtainable by echo Doppler. 
 
Index Terms—Aortic Stenosis, Pulmonary Hypertension, 
Invasive Hemodynamics 
 
I. BACKGROUND 
EVERE pulmonary hypertension is prevalent as high as 
29% in patient with severe aortic stenosis and 
significantly increases morbidity and mortality in these 
patients. Early Aortic Valve Replacement (AVR) for this high-
risk subset of patients with Aortic Stenosis (AS) has been 
recommended (1).The etiology of Pulmonary Hypertension  
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(PHT) in severe AS remains unclear however left ventricular 
(LV) dysfunction may be of one important etiology (2). Prior 
to AVR all patients undergo coronary angiography but 
hemodynamic cardiac catheterization is performed in minority 
of patients, consistent with current practices (3). Transthoracic 
echocardiography (TTE) is relied upon to measure the 
pulmonary artery systolic pressure using the modified 
Bernoulli equation. However, this may not accurately assess 
the right ventricular systolic pressure in some cases due to 
suboptimal tracing of the regurgitation jet, decreased tricuspid 
jet velocity due to high right atrial pressure or poor estimation 
of right atrial pressures, and generally poor technique for 
several reasons (4). Correlations between echo-derived right 
ventricular pressure and measured pulmonary artery systolic 
pressure (PASP) by right heart catheterization (RHC) have 
been reported to be poor when assessed in patients with 
pulmonary disease (5, 6). No studies have compared 
echocardiographic assessment of PHT in AS with invasively 
obtained pulmonary artery pressure using RHC. The reliability 
of echocardiographic detection and degree of PHT in patients 
with AS is unknown. The gold standard for diagnosing PHT 
has been RHC. At our center, we perform hemodynamic 
measurements on all patients with aortic stenosis planning to 
undergo valve replacement. We report the unreliability of 
echocardiographic measurements when assessing for degree of 
stenosis and PHT.  
 
II. MATERIALS AND METHODS 
Approval was obtained from the Institutional Review Board 
at Indiana University, Indianapolis, Indiana for this 
retrospective study. Cardiac Catheterization Lab database 
from an inner city tertiary care center was used to retrieve 
patients with AS. At our center, all patients with AS undergo 
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hemodynamic measurements with coronary angiography. Data 
from June 1999 to June 2008 was obtained. Patients with aortic 
stenosis felt to be significant by 2-D echocardiography or 
clinically symptomatic, had been referred for LHC and RHC. 
Our study population included all patients with AS undergoing 
both LHC and RHC. Only patients who underwent 
hemodynamic studies within 1 month from the time of 
echocardiography were included in the study. 
Severe AS was defined as AVA of <1 cm2 on cardiac 
catheterization. PHT was defined as PASP of >35 mm Hg and 
severe PHT was defined as PASP of > 55 mm Hg. Clinical 
parameters retrieved included age, race, gender, severity of 
aortic stenosis and hemodynamic parameters. 
Echocardiographic parameters were obtained from reports that 
were retrieved from an electronic database.  Echo reports were 
read by attending physicians from the division of cardiology. 
All echocardiograms were reviewed by the author to reconfirm 
the RVSP using the modified Bernoulli equation (4 x TR 
Velocity2+ right atrial pressure). 
Data was analyzed using SPSS version 16. Linear regression 
analysis and Pearson correlation analysis was used to assess 
relationship between linear parameters. Bland-Altman curves 
were plotted using Graph Pad Prism 5. Chi-square testing was 
used to assess significance between groups. 
 
III. RESULTS 
From June 1999 to June 2008, 56 patients with aortic 
stenosis underwent LHC and RHC. Patients with AVA of >1 
cm2 on echocardiography had LHC and RHC if they were 
having symptoms of angina, syncope or worsening dyspnea on 
exertion. Patient demographics and severity of AS are shown 
inTable1. 52 out of 56 patients had pulmonary hypertension 
with PASP > 30 mm Hg. (92.8%). 20 out of 56 patients had 
severe pulmonary hypertension with PASP > 55 mm Hg 
(35.1%). 34.2 % if PVR <3 excluded. If patients with disease 
conditions that could cause PHT were excluded, the 
prevalence of severe PHT was 31.8 %. 
Hemodynamic measurements are illustrated in Table 2.  
RVSP on Echocardiography ranged from 20 to 80 mm Hg 
(mean =32.3). ECHO was unable to assess the RVSP in 5 
patients due to poor TR velocity tracing.  
18 patients (31.5 %) had RVSP > 40 mm Hg. Among patients 
with ECHO RVSP >40 mm Hg, only 1 patient had normal 
pulmonary pressures on RHC hemodynamic measurement.  
34 patients had ECHO RVSP <40 mm Hg. 9 out of 34 (25.7%) 
of these patients had severe PHT on RHC. 
Using a RVSP cutoff of 40 mm Hg, echocardiography had  
 
Patient   
Demographics 
Range (Mean) 
TOTAL PATIENTS 
WITH AS 
AGE 
GENDER 
      Male 
      Female 
RACE 
      Caucasian 
      Blacks 
      Hispanic 
      Oriental 
WEIGHT 
AS SEVERITY 
(Aortic Valve Area 
on Cath) 
      Mild (1.5-1.8) 
      Moderate (1.0 to 
1.5) 
      Severe (<1.0) 
      Unknown 
 
CAD 
 
OSA 
COPD 
OTHER 
VALVULAR 
DISEASE 
     Severe MR, TR or 
AR 
     Moderate  
56 patients 
41 – 84 (61.8) years 
 
43 % (24 patients) 
57 % (32 patients) 
 
55.4% (31 patients) 
30.4% (17 patients) 
12.5% (7 patients) 
0.02 % (1 patient) 
126 – 314 lbs (190.45 ± 
46.8) 
 
   
18% (10 patients) 
  20% (11 patients) 
  55% (31 patients) 
    7% (4 patients ) 
  
36% (20 
patients)
  
 
5.3 % (3 patients) 
3.5 % (2 patients) 
 
 
11 % (6 patients) 
21% (12 patients) 
 
Table 1: Demographics 
 
46.8 % sensitivity (95% CI 0.29-0.64) and 100 % specificity 
(95% CI 0.74-1) to detect pulmonary hypertension in patients 
with aortic stenosis. (Table 4).  Correlations between 
hemodynamic parameters are shown in Table3. There was 
significant correlation between AVA as measured by LHC vs. 
ECHO, however there was tendency for TTE to overestimate 
the AVA (Fig 1A) and the two methods showed little 
agreement per the Bland-Altman plot. There was positive 
correlation between measured PASP by RHC and patient’s 
bodyweight (Fig 2). There was significant correlation between 
 
Fig. 1A.  Correlation between aortic valve area as reported by catherization 
versus echocardiogram R2=0.308 p<0.0001 
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PASP and RVSP measured by ECHO (Fig 3A) but a Bland-
Altman plot shows poor agreement between the two methods 
(Fig 3B). There was a significant correlation between PASP 
and LVEDP (Fig 4). When patients with PVR >3 were 
excluded, there was stronger correlation between PASP and 
LVEDP with R=0.655 p=0.0001. There was still no correlation 
between degree of AVA and PASP   (R= - 0.023   p=0.892). 
The presence of aortic, mitral regurgitation, OSA or COPD did 
not correlate with the degree of PASP. (R=0.013 p=0.939). 
Correlation between PASP and RVSP on ECHO was 
significant (R=0.326 p=0.046). There was no significant 
correlation between PASP and Ejection Fraction. (R=-0.295 
p=0.136). 
 
All cause mortality within 3 years was 44% (8/18) in 
patients with PASP >55 mm Hg. Patients with PASP <55 had 
a mortality of 10.7% (3/28). There was statistically significant 
higher mortality in patients with severe PHT on Chi Square 
Testing (p <0.01, 95% CI). Mean PASP in the group with 
mortality within 3 years was 65.6 mm Hg compared to 48.3 
mm Hg to the group that was alive at 3 years.  
 
 
 
Fig 1B. Bland-Altman plot of aortic valve area as calculated by 
echocardiogram versus cardiac catheterization. 
 
IV. DISCUSSION 
Coronary angiography is routinely performed in patients 
with aortic stenosis with symptoms of angina to identify 
concomitant coronary artery disease. Some centers choose to 
obtain a hemodynamic assessment during the cardiac 
catheterization study however this is not routinely done. 
Connelly et al showed a gradual decrease in hemodynamic 
cardiac catheterization since 1990 at the Mayo Clinic with less 
than 15% of patients undergoing hemodynamic cardiac 
catheterization in 1998 and 1999 for assessment of valvular 
hemodynamics (3). This decrease is mostly due to the 
diagnostic certainty of hemodynamics, thought to be provided 
by echocardiography. TTE may reliably assess the severity of 
aortic stenosis as compared to left heart catheterization 
hemodynamics (10). However, no prior studies have compared 
right heart catheterization hemodynamics with TTE in aortic 
stenosis.  
 
Arcasoy et al (11) and Swanson et al (12) showed that in 
patients with advanced lung disease, right ventricular systolic 
pressure obtained with Doppler echocardiography is not 
reliably accurate in assessment of pulmonary hypertension. To 
our knowledge, our study is the first to compare the ability of 
echo Doppler to reliably assess for pulmonary hypertension 
comparing it to the gold standard of invasive hemodynamic 
measurements. 
 
Prior studies have mostly used echocardiography to assess 
the degree of pulmonary hypertension. Johnson et al (13) and 
Faggiono et al (9) used invasive hemodynamics to assess 
degree of pulmonary hypertension in aortic stenosis and found 
the prevalence to be as high as 50% and 65 % respectively. 
Our study showed 93 % of patients with symptomatic aortic 
stenosis had PHT. Severe PHT was found in 35%. We report 
the highest prevalence of PHT in our population of patients 
with aortic stenosis. Even if patients with other medical 
conditions such as chronic obstructive lung disease, 
obstructive sleep apnea, and mitral or aortic insufficiency were  
 
HEMODYNAMIC 
MEASUREMENT 
RANGE ( MEAN ) 
LVEDP 
LVEF 
PASP 
PCWP 
PVR 
ECHO-RVSP 
7 – 41 (23.5)  mm Hg 
15 – 75 % (50%) 
22  - 118 (52.5) 
7 – 40 (20)  mm Hg 
1.21 – 7.6 (3.1) 
20-80 (32.3) mm Hg 
 
Table 2 : Legend: PASP – Pulmonary Artery Systolic Pressure,  LVEDP – 
Left Ventricular End Diastolic Pressure,  PVR – Pulmonary Vascular 
Resistant, LVEF – Left Ventricular Ejection Fraction 
PCWP – Pulmonary Capillary Wedge Pressure 
 
excluded, prevalence of severe PHT was up to 30 %.   Prior 
studies showed severe PHT to be 15-16% (9, 13). There was a 
positive correlation between weight and PASP obtained by 
catheterization, which is consistent with Weyman et al 
assessment of PASP obtained by echocardiography of normal 
subjects (18). The degree of obesity in our study population 
was a likely contributing factor to such a high prevalence of 
PHT. Obese patients are more likely to have poor quality 
studies, making it difficult to estimate the TR velocity (14). 
Regardless of the cause of PHT, these patients are at higher 
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risk of morbidity and mortality. The presence of pulmonary 
hypertension was also independent of underlying medical 
problems such as COPD, OSA or valvular regurgitation. 
Pulmonary hypertension may develop even in patients with 
mild aortic stenosis. It is unclear why certain patients with 
aortic stenosis develop severe PHT. Recently E/E’ ratio on 
echo has been shown to be of prognostic value which points to 
diastolic dysfunction as a likely etiology (17). Our study also 
suggests that elevated LVEDP obtained by hemodynamics, 
correlates well with the severity of pulmonary HTN. However 
Siegel et al, showed no prognostic significance of PASP, based 
on echo-doppler. Prior studies showed that severe pulmonary 
hypertension is an independent predictor of perioperative 
mortality and early AVR has been recommended for this sub-
group even when asymptomatic (7). Reversibility of PHT after 
AVR in patients with AS has been shown (8). This suggests 
relieving the aortic obstruction improves the LVEDP and 
subsequently, lowers the pulmonary pressure. The etiology of 
pulmonary hypertension in aortic stenosis remains unclear. 
Severity of pulmonary hypertension was independent of 
severity of aortic stenosis. This is consistent with the findings 
of Faggiano et al that PASP showed no relation to aortic valve 
area in patients with PHT and isolated AS (9). We found a 
weak albeit significant correlation between PASP measured by 
right heart hemodynamics and LVEDP measured by left heart 
catherization which is also consistent with prior studies (9, 13). 
A PVR > 3 suggests intrinsic pulmonary cause of pulmonary 
hypertension. In patients with PVR < 3, there was a stronger 
correlation between LVEDP and PASP suggesting diastolic 
dysfunction may be the initial insult in aortic stenosis leading 
to pulmonary hypertension. There was a higher 3- year  
 
 
 
Fig. 2 There was a significant correlation betweens patients body weight and 
PASP obtained on cardiac catheterization.   (R2= 0.224  P=0.002) 
 
mortality in patients with severe PHT, which is consistent with 
prior studies. There was a significant correlation between 
AVA measured by left heart catherization and 
echocardiography. However, echocardiography overestimates 
the severity of aortic stenosis and is unreliable when using 
AVA obtained by catheterization as a gold standard. 
Echocariographic measurements underestimate the number 
and severity of patients with pulmonary hypertension in aortic 
stenosis. By echocardiography alone, 31.5 % patients with 
aortic stenosis had PHT, which is consistent with prior studies 
(1). But if echocardiography were used alone, 25% of patients 
with severe PHT would be missed.  Echocardiography testing 
that was unable to detect right heart pressures or detected 
normal pressures were considered missed diagnoses. Some 
patients in this group had such severe pulmonary hypertension 
that surgery would be contra-indicated. 
 
 
                     PARAMETERS r  p Value 
  
AVA-ECHO  and AVA-
Cardiac Cath 
PASP and ECHO-RVSP 
PASP and LVEDP 
PASP and LVEDP * 
PASP and AVA-Cardiac Cath 
AVA-Cardiac Cath and LVEDP 
PASP and LVEF-Cardiac Cath 
PASP and Weight 
 
  0.555 
  0.344 
  0.348 
  0.655 
- 0.105 
 -0.141 
 -0.296 
  0.473 
 
<0.0001 
  0.009 
  0.024 
 
<0.0001 
  0.24 
  0.419 
  0.136 
  0.002 
 
Table 3 
 
 
 
 
Fig. 3A Correlation between PASP obtained by hemodynamic measurement 
with catheterization vs. RVSP obtained on echocardiogram. There was 
correlation ( R2=0.208  p<0.01) however , using a cutoff of 55 mm Hg as 
moderate pulmonary HTN , there was a high number of false positives when 
echocardiogram is used to assess severity of pulmonary HTN. 
 
Echocardiography had a sensitivity of 46.8% and a 
specificity of 100% for detecting pulmonary hypertension. 
This low sensitivity is consistent with studies that compared 
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echocardiography with RHC in other disease conditions that 
cause PHT (5, 15, and 16). Despite such a high specificity, due 
to such a low sensitivity of echocardiography in detecting 
PHT, RHC should be considered in patients with aortic 
stenosis when there is a concern for PHT.    
 
 
 
PASP  (mm Hg) 
<40 >40 Total 
ECHO 
RVSP 
(mm Hg) 
<40 
15 17 32 
>40 0 15 15 
Total 15 32 47 
 
Table 4 Sensitivity – TP/TP+FN = 0.46875 (95% CI 0.29 – 0.64) 
Specificity – TN/FP + TN = 1 (95% CI 0.74 – 1) 
 
 
 
 
 
Fig. 3B. Bland-Altman plot of PASP determined by catheterization versus 
echocardiogram 
 
V. LIMITATIONS 
Our study did not compare aortic stenosis patients with and 
without pulmonary hypertension. There were a very small 
number of patients with no pulmonary hypertension. Surgical 
outcomes were not evaluated. It is not known if the presence 
of pulmonary hypertension across all severities of aortic 
stenosis concurs a poor prognosis. The duration of symptoms 
in our patients was not evaluated .The degree of pulmonary 
hypertension may vary with duration of symptoms. Our data 
base was limited to those patients with aortic stenosis who 
underwent cardiac catherization. Patients who were found to 
have mild aortic stenosis on echocardiography may not have 
been referred for hemodynamic studies. Also, pulmonary 
function tests and sleep studies were not available in all 
patients. We relied on previously documented disease or 
clinical symptoms .Some of our patients may have had an 
undiagnosed condition causing the pulmonary hypertension. 
 
 
Fig. 4 – Correlation between LVEDP and PASP obtained on cardiac 
catheterization. (R2=0.121  p<0.05 ) 
 
VI. CONCLUSION 
Pulmonary hypertension is highly prevalent in patients with 
all degrees of severity of aortic stenosis. Severe pulmonary 
hypertension was found in up to 35% of patients with aortic 
stenosis even after excluding patients with conditions that 
could potentially cause pulmonary hypertension. 
Echocardiographic assessment of RVSP correlates with PASP 
assessed by right heart hemodynamics however 
echocardiography underestimates pulmonary hypertension in 
patients with aortic stenosis, possessing a sensitivity of only 
48%. RHC provides a more accurate assessment of PASP. 
PASP correlates with LVEDP, suggesting that diastolic 
dysfunction of the left heart (elevated LVEDP) and of the right 
heart (elevated RVEDP) may be at least in part be contributing 
to the elevated pulmonary pressures. Elevated left atrial 
pressure with backward transmission to the pulmonary veins 
and the pulmonary capillaries may also be responsible. 
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